FDA Drug Application (020951) for TAGAMET HB 200 by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020951
Product Number001
FormSUSPENSION;ORAL
Dosage200MG/20ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAGAMET HB 200
Active IngredientCIMETIDINE

Active IngredientCount
List of drugs with Active Ingredient CIMETIDINE4


Back to FDA Applications sponsored by GLAXOSMITHKLINE